Treace Medical Concepts, (id:7658 TMCI)
7.94 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/22/2024 7:13:27 AM)
Exchange closed, opens in 2 hours 16 minutes
-1.49 USD (-1.49%)
3.66 USD (3.66%)
52.40 USD (52.40%)
51.24 USD (51.24%)
-9.46 USD (-9.46%)
-67.59 USD (-67.59%)
About Treace Medical Concepts,
Market Capitalization 493.39M
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
| Headquarters (address) |
100 Palmetto Park Place Ponte Vedra 32081 FL United States |
| Phone | 904 373 5940 |
| Website | https://www.treace.com |
| Employees | 516 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | TMCI |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 3.92 - 15.98 |
| Market Capitalization | 493.39M |
| P/E trailing | -9.85 |
| P/E forward | -10.17 |
| Price/Sale | 2.43 |
| Price/Book | 4.53 |
| Beta | 0.240 |
| EPS | -0.950 |
| EPS United States (ID:6, base:3395) | 24.30 |